Which of the following concerning the use of the “benchmark dose” in risk assessment is NOT correct?
A.) can use the full range of doses and responses studied
B.) allows use of data obtained from experiments where a clear “no observed adverse effect level” (NOAEL) has been attained
C.) may be defined as the lower confidence limit on the 10% effective dose
D.) is primarily used for analyses of carcinogenicity data and has limited utility for analyses of developmental and reproduction studies that generate quantal data
Answer:D
Which of the following concerning the use of the “benchmark dose” in risk assessment is NOT correct?
A.) can use the full range of doses and responses studied B.) allows use of data obtained from experiments where a clear “no observed adverse effect level” (NOAEL) has been attained C.) may be defined as the lower confidence limit on the 10% effective dose D.) is primarily used for analyses of carcinogenicity data and has limited utility for analyses of developmental and reproduction studies that generate quantal data